Cargando…

Co-regulation and function of FOXM1/RHNO1 bidirectional genes in cancer

The FOXM1 transcription factor is an oncoprotein and a top biomarker of poor prognosis in human cancer. Overexpression and activation of FOXM1 is frequent in high-grade serous carcinoma (HGSC), the most common and lethal form of human ovarian cancer, and is linked to copy number gains at chromosome...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barger, Carter J, Chee, Linda, Albahrani, Mustafa, Munoz-Trujillo, Catalina, Boghean, Lidia, Branick, Connor, Odunsi, Kunle, Drapkin, Ronny, Zou, Lee, Karpf, Adam R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	eLife Sciences Publications, Ltd 2021
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104967/ https://www.ncbi.nlm.nih.gov/pubmed/33890574 http://dx.doi.org/10.7554/eLife.55070

Ejemplares similares

Pan-Cancer Analyses Reveal Genomic Features of FOXM1 Overexpression in Cancer
por: Barger, Carter J, et al.
Publicado: (2019)

Genetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression
por: Barger, Carter J., et al.
Publicado: (2015)

FOXM1: A Multifunctional Oncoprotein and Emerging Therapeutic Target in Ovarian Cancer
por: Liu, Cassie, et al.
Publicado: (2021)

Expression of the POTE gene family in human ovarian cancer
por: Barger, Carter J, et al.
Publicado: (2018)

The lncRNA Rhno1/miR-6979-5p/BMP2 Axis Modulates Osteoblast Differentiation
por: Xiong, Yuan, et al.
Publicado: (2020)

NPM-ALK Is a Key Regulator of the Oncoprotein FOXM1 in ALK-Positive Anaplastic Large Cell Lymphoma
por: Haque, Moinul, et al.
Publicado: (2019)

DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer
por: Zhang, Wa, et al.
Publicado: (2015)

Global DNA Hypomethylation in Epithelial Ovarian Cancer: Passive Demethylation and Association with Genomic Instability
por: Zhang, Wa, et al.
Publicado: (2020)

PRAME expression and promoter hypomethylation in epithelial ovarian cancer
por: Zhang, Wa, et al.
Publicado: (2016)

MELK-Dependent FOXM1 Phosphorylation is Essential for Proliferation of Glioma Stem Cells
por: Joshi, Kaushal, et al.
Publicado: (2013)

Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
por: Tran, Gia-Buu, et al.
Publicado: (2023)

FOXM1 predicts disease progression in non-muscle invasive bladder cancer
por: Rinaldetti, Sebastien, et al.
Publicado: (2018)

Pathogenesis and heterogeneity of ovarian cancer
por: Kroeger, Paul T., et al.
Publicado: (2017)

FOXM1: Functional Roles of FOXM1 in Non-Malignant Diseases
por: Zhang, Zhenwang, et al.
Publicado: (2023)

Estrogen Receptor-Beta2 (ERβ2)–Mutant p53–FOXM1 Axis: A Novel Driver of Proliferation, Chemoresistance, and Disease Progression in High Grade Serous Ovarian Cancer (HGSOC)
por: Oturkar, Chetan C., et al.
Publicado: (2022)

WHSC1/NSD2 regulates immune infiltration in prostate cancer
por: Want, Muzamil Y, et al.
Publicado: (2021)

Prognostic significance of FOXM1 expression and antitumor effect of FOXM1 inhibition in synovial sarcomas
por: Maekawa, Akira, et al.
Publicado: (2016)

H2Bub1: Guardian of chromatin accessibility in ovarian cancer
por: Reavis, Hunter, et al.
Publicado: (2019)

Prognostic Significance of Forkhead Box M1 (FOXM1) Expression and Antitumor Effect of FOXM1 Inhibition in Angiosarcoma
por: Ito, Takamichi, et al.
Publicado: (2016)

The cell-penetrating FOXM1 N-terminus (M1-138) demonstrates potent inhibitory effects on cancer cells by targeting FOXM1 and FOXM1-interacting factor SMAD3
por: Zhang, Zhenwang, et al.
Publicado: (2019)

Honokiol is a FOXM1 antagonist
por: Halasi, Marianna, et al.
Publicado: (2018)

How lung cancer cells change identity
por: von Itzstein, Mitchell S, et al.
Publicado: (2021)

FoxM1 is Upregulated in Osteosarcoma and Inhibition of FoxM1 Decreases Osteosarcoma Cell Proliferation, Migration, and Invasion
por: Zhu, Xia, et al.
Publicado: (2020)

FOXM1c is the predominant FOXM1 isoform expressed in cholangiocarcinoma that associated with metastatic potential and poor prognosis of patients
por: Klinhom-on, Nathakan, et al.
Publicado: (2021)

CCNE1 copy number is a biomarker for response to combination WEE1-ATR inhibition in ovarian and endometrial cancer models
por: Xu, Haineng, et al.
Publicado: (2021)

Crosstalk between protein kinase C α and transforming growth factor β signaling mediated by Runx2 in intestinal epithelial cells
por: Li, Xinyue, et al.
Publicado: (2023)

FOXM1 Is an Oncogenic Mediator in Ewing Sarcoma
por: Christensen, Laura, et al.
Publicado: (2013)

Regulation of the master regulator FOXM1 in cancer
por: Liao, Guo-Bin, et al.
Publicado: (2018)

The multifaceted roles of FOXM1 in pulmonary disease
por: Li, Yumei, et al.
Publicado: (2019)

Aberrantly high activation of a FoxM1–STMN1 axis contributes to progression and tumorigenesis in FoxM1-driven cancers
por: Liu, Jun, et al.
Publicado: (2021)

Whole‐exome sequencing of ovarian cancer families uncovers putative predisposition genes
por: Zhu, Qianqian, et al.
Publicado: (2019)

Circ-FOXM1 promotes the proliferation, migration and EMT process of osteosarcoma cells through FOXM1-mediated Wnt pathway activation
por: Zhang, Hao, et al.
Publicado: (2022)

The oncogenic transcription factor FOXM1 and anticancer therapy
por: Gartel, Andrei L.
Publicado: (2012)

The roles of FOXM1 in pancreatic stem cells and carcinogenesis
por: Quan, Ming, et al.
Publicado: (2013)

Mutual Regulation of FOXM1, NPM and ARF Proteins
por: Pandit, Bulbul, et al.
Publicado: (2015)

Overexpression of FOXM1 is associated with metastases of nasopharyngeal carcinoma
por: Jiang, Lizhu, et al.
Publicado: (2014)

FOXM1b, which is present at elevated levels in cancer cells, has a greater transforming potential than FOXM1c
por: Lam, Andy K. Y., et al.
Publicado: (2013)

A novel FOXM1 isoform, FOXM1D, promotes epithelial–mesenchymal transition and metastasis through ROCKs activation in colorectal cancer
por: Zhang, X, et al.
Publicado: (2017)

FOXM1a Isoform of Oncogene FOXM1 Is a Tumor Suppressor Suppressed by hnRNP C in Oral Squamous Cell Carcinoma
por: Jia, Rong, et al.
Publicado: (2023)

The FOXM1-PLK1 axis is commonly upregulated in oesophageal adenocarcinoma
por: Dibb, M, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_q28oe7kieg285lk3slnnoo5c4b